January 16, 2015Open Access

Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial

Key Points

Key points are not available for this paper at this time.

Abstract

Terlipressin plus albumin is significantly more effective than midodrine and octreotide plus albumin in improving renal function in patients with HRS.

AI에게 질문

Bookmark

View Full Paper

Cite This Study

Cavallin et al. (Fri,) studied this question.

synapsesocial.com/papers/69dad1a478a3e0e28868476d https://doi.org/https://doi.org/10.1002/hep.27709

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: Relationship of serum creatinine to hemodynamics2010 · 248 citations
2Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: A randomized study2012 · 268 citations
3Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis2014 · 110 citations
4Systematic Review of Randomized Trials on Vasoconstrictor Drugs for Hepatorenal Syndrome2009 · 293 citations
5Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis1996 · 7,150 citations

AI에게 질문

Bookmark

View Full Paper